Category Filter

Policies & Guidelines

Asset Publisher

Content with Policies & Guidelines Provider-Administered Drug Claim Edit Policies .

Emend

Aralast NP; Glassia; Prolastin-C; Zemaira®

Lupron Depot, Lupron Depot-Ped, Eligard, Fensolvi, Camcevi, Lutrate Depot™, Leuprolide Acetate Depot

Prolia; Xgeva

Sandostatin LAR

Trelstar

Vantas

Velcade, Bortezomib

Zoladex

Fusilev, Khapzory

Dysport

Xeomin

Aranesp

Mircera

print Print Back Back Bortezomib* Policy Number: PH-0351   Intravenous Only   Last Review Date:...

print Print Back Back Fosaprepitant: Emend®; Fosaprepitant Ψ (Intravenous) Policy Number: VP-036 Last Review...